ChengDu, undefined

Weili Wan

This inventor holds 1 USPTO granted patent. Top assignee: Sichuan Baili Pharmaceutical Co., Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weili Wan. Retrieved from https://idiyas.com/inventor/weili-wan-a9m8kfyy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Weili Wan: Innovator in Pharmaceutical Chemistry

Introduction

Weili Wan is a notable inventor based in ChengDu, Sichuan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on drug derivatives.

Latest Patents

Weili Wan holds a patent for a "Camptothecin Derivative and Conjugate Thereof." This invention showcases his expertise in developing new pharmaceutical compounds that can potentially enhance therapeutic efficacy.

Career Highlights

Currently, Weili Wan is employed at Sichuan Baili Pharmaceutical Co., Ltd. His role at this company allows him to apply his knowledge and skills in a practical setting, contributing to the advancement of pharmaceutical products.

Collaborations

Weili Wan collaborates with talented individuals such as Yi Zhu and Tao K Xu. These partnerships enhance the innovative capacity of their projects and foster a collaborative environment in their research endeavors.

Conclusion

Weili Wan's contributions to pharmaceutical chemistry, particularly through his patent on camptothecin derivatives, highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…